TheranosticTrials.org

Clinical Trial · NCT05884463

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Overview

To explore the potential efficacy of 18F-FAPI-04 PET/CT for PDAC tumour staging and compare the results with those obtained using 18F-FDG PET/CT.

Sponsor

Zhejiang University

Phase

N/A

Contacts

Tingbo Liang, Ph.D., M.D. (STUDY_DIRECTOR)

ClinicalTrials.gov

NCT05884463

Drug / Compound

FAPI-04

Isotope(s):
Target(s):
  • FAP
Ligand Class: Small Molecules
Chelator: DOTA

FDG

Isotope(s):
Target(s):
  • Glucose Transport
Ligand Class: Small Molecules

Eligibility

Inclusion

Inclusion criteria not yet provided.

Exclusion

  • patients with a history of severe contrast allergy pregnant patients patients who were not pathologically diagnosed as showing PDAC.